Genmab | GEN - Debt



Genmab reported DKK148M in Debt for its fiscal quarter ending in June of 2025.


Debt Change Date
Agios Pharmaceuticals USD 48.76M 48.76M Jun/2025
Almirall EUR 341.5M 67.31M Mar/2025
Amarin USD 0 0 Mar/2025
Amgen USD 56.2B 1.18B Jun/2025
argenx SE 43.15M 4.1M Jun/2025
AstraZeneca USD 32.84B 1.19B Jun/2025
Bayer EUR 39.39B 1.31B Mar/2025
BioMarin Pharmaceutical USD 603.87M 8.22M Jun/2025
Demant DKK 15.68B 146M Dec/2024
Exelixis USD 179.84M 179.84M Jun/2025
Fresenius Medical Care EUR 11.02B 203.55M Jun/2025
Galapagos EUR 10.86M 864K Mar/2025
Genmab DKK 148M 5M Jun/2025
GlaxoSmithKline GBP 17.35B 1.08B Jun/2025
GN Store Nord DKK 11.77B 1.46B Mar/2025
GRIFOLS EUR 8.82B 1.23B Jun/2025
Hikma Pharmaceutical USD 1.31B 30M Dec/2024
Insmed USD 564.1M 567.29M Jun/2025
Lonza CHF 4.71B 915M Dec/2024
Merck EUR 9.4B 704M Jun/2025
Novartis USD 31.27B 12M Mar/2025
Regeneron Pharmaceuticals USD 2.71B 300K Jun/2025
Roche Holding CHF 34.44B 5.23B Jun/2024
Sanofi 22.28B 1.24B Jun/2025
UCB EUR 3.03B 12M Dec/2024